Literature DB >> 26288260

Multicomponent Synthesis and Biological Evaluation of a Piperazine-Based Dopamine Receptor Ligand Library.

Mattia Stucchi1, Peter Gmeiner2, Harald Huebner2, Giulia Rainoldi1, Alessandro Sacchetti3, Alessandra Silvani1, Giordano Lesma1.   

Abstract

A series of 1,4-disubstituted piperazine-based compounds were designed, synthesized, and evaluated as dopamine D2/D3 receptor ligands. The synthesis relies on the key multicomponent split-Ugi reaction, assessing its great potential in generating chemical diversity around the piperazine core. With the aim of evaluating the effect of such diversity on the dopamine receptor affinity, a small library of compounds was prepared, applying post-Ugi transformations. Ligand stimulated binding assays indicated that some compounds show a significant affinity, with K i values up to 53 nM for the D2 receptor. Molecular docking studies with the D2 and D3 receptor homology models were also performed on selected compounds. They highlighted key interactions at the indole head and at the piperazine moiety, which resulted in good agreement with the known pharmacophore models, thus helping to explain the observed structure-activity relationship data. Molecular insights from this study could enable a rational improvement of the split-Ugi primary scaffold, toward more selective ligands.

Entities:  

Keywords:  D2/D3 dopamine receptor; Multicomponent reaction; molecular docking; split-Ugi

Year:  2015        PMID: 26288260      PMCID: PMC4538446          DOI: 10.1021/acsmedchemlett.5b00131

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  23 in total

1.  Interactive SAR studies: rational discovery of super-potent and highly selective dopamine D3 receptor antagonists and partial agonists.

Authors:  Laura Bettinetti; Karin Schlotter; Harald Hübner; Peter Gmeiner
Journal:  J Med Chem       Date:  2002-10-10       Impact factor: 7.446

2.  Modeling of G-protein-coupled receptors: application to dopamine, adrenaline, serotonin, acetylcholine, and mammalian opsin receptors.

Authors:  S Trumpp-Kallmeyer; J Hoflack; A Bruinvels; M Hibert
Journal:  J Med Chem       Date:  1992-09-18       Impact factor: 7.446

3.  Structure-activity relationship study of N⁶-(2-(4-(1H-Indol-5-yl)piperazin-1-yl)ethyl)-N⁶-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine analogues: development of highly selective D3 dopamine receptor agonists along with a highly potent D2/D3 agonist and their pharmacological characterization.

Authors:  Mark Johnson; Tamara Antonio; Maarten E A Reith; Aloke K Dutta
Journal:  J Med Chem       Date:  2012-06-13       Impact factor: 7.446

4.  A mimicry of primary amines by bis-secondary diamines as components in the Ugi four-component reaction.

Authors:  Giovanni Battista Giovenzana; Gian Cesare Tron; Stefano Di Paola; Ivan Guglielmo Menegotto; Tracey Pirali
Journal:  Angew Chem Int Ed Engl       Date:  2006-02-06       Impact factor: 15.336

5.  Modification of agonist binding moiety in hybrid derivative 5/7-{[2-(4-aryl-piperazin-1-yl)-ethyl]-propyl-amino}-5,6,7,8-tetrahydro-naphthalen-1-ol/-2-amino versions: impact on functional activity and selectivity for dopamine D2/D3 receptors.

Authors:  Bhaskar Gopishetty; Suhong Zhang; Prashant S Kharkar; Tamara Antonio; Maarten Reith; Aloke K Dutta
Journal:  Bioorg Med Chem       Date:  2013-04-01       Impact factor: 3.641

Review 6.  Recent advances in the search for D3- and D4-selective drugs: probes, models and candidates.

Authors:  Stefan Löber; Harald Hübner; Nuska Tschammer; Peter Gmeiner
Journal:  Trends Pharmacol Sci       Date:  2011-01-12       Impact factor: 14.819

7.  Antipsychotic haloperidol binding to the human dopamine D3 receptor: beyond docking through QM/MM refinement toward the design of improved schizophrenia medicines.

Authors:  Geancarlo Zanatta; Gustavo Nunes; Eveline M Bezerra; Roner F da Costa; Alice Martins; Ewerton W S Caetano; Valder N Freire; Carmem Gottfried
Journal:  ACS Chem Neurosci       Date:  2014-09-18       Impact factor: 4.418

8.  AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility.

Authors:  Garrett M Morris; Ruth Huey; William Lindstrom; Michel F Sanner; Richard K Belew; David S Goodsell; Arthur J Olson
Journal:  J Comput Chem       Date:  2009-12       Impact factor: 3.376

9.  Molecular basis for the binding of 2-aminotetralins to human dopamine D2A and D3 receptors.

Authors:  A Malmberg; G Nordvall; A M Johansson; N Mohell; U Hacksell
Journal:  Mol Pharmacol       Date:  1994-08       Impact factor: 4.436

10.  Structural modifications of neuroprotective anti-Parkinsonian (-)-N6-(2-(4-(biphenyl-4-yl)piperazin-1-yl)-ethyl)-N6-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine (D-264): an effort toward the improvement of in vivo efficacy of the parent molecule.

Authors:  Gyan Modi; Tamara Antonio; Maarten Reith; Aloke Dutta
Journal:  J Med Chem       Date:  2014-02-12       Impact factor: 7.446

View more
  4 in total

1.  Novel Bivalent Ligands Based on the Sumanirole Pharmacophore Reveal Dopamine D2 Receptor (D2R) Biased Agonism.

Authors:  Alessandro Bonifazi; Hideaki Yano; Michael P Ellenberger; Ludovic Muller; Vivek Kumar; Mu-Fa Zou; Ning Sheng Cai; Adrian M Guerrero; Amina S Woods; Lei Shi; Amy Hauck Newman
Journal:  J Med Chem       Date:  2017-03-16       Impact factor: 7.446

2.  Enantiopure β-isocyano-boronic esters: synthesis and exploitation in isocyanide-based multicomponent reactions.

Authors:  Marco Manenti; Simone Gusmini; Leonardo Lo Presti; Giorgio Molteni; Alessandra Silvani
Journal:  Mol Divers       Date:  2022-10-19       Impact factor: 3.364

3.  Synthesis, Molecular Properties Estimations, and Dual Dopamine D2 and D3 Receptor Activities of Benzothiazole-Based Ligands.

Authors:  Moritz Schübler; Bassem Sadek; Tim Kottke; Lilia Weizel; Holger Stark
Journal:  Front Chem       Date:  2017-09-12       Impact factor: 5.221

4.  Isonitrile-Based Multicomponent Synthesis of β-Amino Boronic Acids as β-Lactamase Inhibitors.

Authors:  Emanuele Bassini; Stefano Gazzotti; Filomena Sannio; Leonardo Lo Presti; Jacopo Sgrignani; Jean-Denis Docquier; Giovanni Grazioso; Alessandra Silvani
Journal:  Antibiotics (Basel)       Date:  2020-05-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.